Call Today: 800-417-9951
Contact us for free information or to start a free case review.
GlaxoSmithKline and the FDA are both warning the public about a new study linking eye problems in diabetic patients who take the diabetes drugs Avandia or Avandamet.
The eye problems, known collectively as macular edema, are the result of leaking blood vessels in the eye. Macular edema can cause blurred vision, a color vision problem, and a change in the way that patients are able to see in the dark. Diabetes patients who are on Avandia or Avandamet are asked to report to their doctors immediately if they notice any eye or sight related problems.
In addition, patients have reported side effects that include swollen feet and legs. In many cases, the symptoms, including the eye problems, ceased or got better when the drug use was stopped. One case of macula edema stopped completely when the dosing level of the drugs was reduced.
Globally over 5 million people have taken Avandia and almost 770,000 have taken Avandamet. Diabetic patients around the world are urged to talk to their doctors or medical healthcare practitioners immediately if they are taking either drug.
Copyright © 2001 - 2012 Online Lawyer Source
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.